glp-1 news today oct 2 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford GLP-1 therapies are changing obesity

Sustainable results require addressing the root causes of weight gain alongside medication, not relying on medication alone

Preliminary data point toward beneficial effects of GIP agonism, as reported in findings from the SURPASS program that tirzepatide reduced UACR and slowed down eGFR declined in comparison with both placebo (53) and comparator drugs including insulin glargine (74, 75)

When these levels drop, the body may struggle to keep up with cellular repair, which can manifest in various ways, including changes in the strength and appearance of your hair

Then there are these plays in India that are trying to be innovators themselves NCE / INNOVATION - The Long-Duration Bets That Are Starting to Pay Off For decades, Indian pharma was synonymous with one word: generics

Addressing Fears of Risk, Recovery, and Judgment Modern bariatric procedures are among the safest elective surgeries in medicine, with risk rates comparable to gallbladder or knee surgery

doi: 10.1038/srep12693 121 ProssomaritiA.PiazziG.AlquatiC.RicciardielloL